Zhang et al. noted the presence of anticardiolipin immunoglobulin A (IgA) antibodies and anti–β2-glycoprotein I IgA and IgG antibodies in patients with COVID-19 who had hypoxemic respiratory failure [81]. Here, CD79A is linked to respiratory failure.